01106nam0 2200277 i 450 SUN006077020110405101046.50415-586-0737-420070803d2002 |0engc50 baengUS|||| |||||Curves and surfaces for CAGDa practical guideGerald Farin5. edSan Francisco [etc.]Morgan Kaufmann2002XVII, 499 p.ill.24 cm.001SUN00607712001 The *Morgan Kaufmann series in computer graphics and geometric modeling210 San FranciscoMorgan Kaufmann.GBLondonSUNL000015Farin, Gerald E.SUNV04437430395KaufmannSUNV001804650Farin, G. E.Farin, Gerald E.SUNV106285ITSOL20210201RICASUN0060770BIBLIOTECA DEL DIPARTIMENTO DI ARCHITETTURA E DISEGNO INDUSTRIALE01PREST IIIAb92 01 6213 20070913 Curves and surfaces for CAGD1104344UNICAMPANIA03022nam 2200685 450 991046475720332120211007220619.01-934536-34-210.9783/9781934536346(CKB)3710000000095191(SSID)ssj0001257800(PQKBManifestationID)11827394(PQKBTitleCode)TC0001257800(PQKBWorkID)11275738(PQKB)11762505(MiAaPQ)EBC3442338(OCoLC)647135952(MdBmJHUP)muse34983(DE-B1597)449740(OCoLC)979969105(DE-B1597)9781934536346(Au-PeEL)EBL3442338(CaPaEBR)ebr10842093(CaONFJC)MIL682599(OCoLC)932313215(EXLCZ)99371000000009519120140312h19821982 uy 0engurcnu||||||||txtccrIntroduction to the archaeology of Tikal, Guatemala /William R. Coe, William A. HavilandPhiladelphia, Pennsylvania :University Museum : :University of Pennsylvania,1982.©19821 online resource (113 pages) illustrations, mapUniversity Museum monograph ;46Tikal Reports ;Number 12Bibliographic Level Mode of Issuance: Monograph1-322-51317-1 0-934718-43-1 Includes bibliographical references.Front matter --CONTENTS --LIST OF ILLUSTRATIONS --ACKNOWLEDGEMENTS --I. Background --II. Personnel --III. Funding --IV. Site Restoration --V. Field Investigations --VI. Procedures in Field and Laboratory --VII. Publication --APPENDIX A. OPERATIONS AND THEIR SUBOPERATIONS: BRIEF FIELD DEFINITIONS, YEARS OF, AND ASSIGNMENT WITHIN THE SERIES OF TIKAL REPORTS --APPENDIX B. BIBLIOGRAPHY OF THE TIKAL PROJECT 1956-1982This volume offers a full review of the work of the Tikal Project of the University of Pennsylvania Museum of Archaeology and Anthropology. Topics include initial motivations and theoretical concerns, procedures and standards used in excavation, a complete inventory of all excavations undertaken, a list of anticipated publications, and a Project bibliography.University Museum Monograph, 46Tikal reports ;no. 12.Excavations (Archaeology)GuatemalaTikal SiteTikal Site (Guatemala)Electronic books.Excavations (Archaeology)972.81/2Coe William Robertson1869-1955.1049118Haviland William A1042312Jay I. Kislak Reference Collection (Library of Congress)MiAaPQMiAaPQMiAaPQBOOK9910464757203321Introduction to the archaeology of Tikal, Guatemala2477835UNINA10735nam 22004573 450 991086523450332120240620080249.09783031596308(electronic bk.)9783031596292(MiAaPQ)EBC31495529(Au-PeEL)EBL31495529(CKB)32315580000041(EXLCZ)993231558000004120240620d2024 uy 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierColoproctology A Practical Guide2nd ed.Cham :Springer International Publishing AG,2024.©2024.1 online resource (358 pages)Print version: Evans, Martyn Coloproctology Cham : Springer International Publishing AG,c2024 9783031596292 Intro -- Contents -- 1 Triage Optimisation in Patients with Symptoms Suspicious of Colorectal Cancer -- 1.1 Introduction -- 1.2 Symptoms Suggestive of Colorectal Cancer -- 1.3 Current Challenges of Diagnosing Colorectal Cancer Amongst Symptomatic Patients -- 1.3.1 Risks of Invasive Investigations -- 1.3.2 Low Patient Acceptability -- 1.3.3 Excessive Investigation and Low Value Healthcare -- 1.3.4 Opportunity Costs Associated with Reliance on Symptoms for Risk Assessment -- 1.3.5 Supply and Demand Imbalance -- 1.4 The Need for Triaging and Defining Optimum -- 1.5 An Overview of Current Approaches to Triaging -- 1.6 The Faecal Immunochemical Test (FIT) -- 1.7 Implementing FIT-A Proposed Triaging Approach -- 1.8 Further Questions -- 1.9 Conclusions -- References -- 2 Total Neoadjuvant Therapy (TNT) in Rectal Cancer -- Where Now, Where Next? -- 2.1 Introduction -- 2.2 Where Are We Now? -- 2.2.1 Induction Chemotherapy -- 2.2.2 Consolidation Chemotherapy -- 2.2.3 Induction Versus Consolidation Chemotherapy Sequencing -- 2.2.4 Total Neoadjuvant Therapy Combined with Immunotherapy or Biologics -- 2.3 Where Next? -- 2.3.1 Personalized Total Neoadjuvant Therapy Sequencing -- 2.3.2 Optimising Chemotherapy Regimen -- 2.3.3 Neoadjuvant Chemotherapy or Immunotherapy with Selective Omission of Radiotherapy -- 2.3.4 Pushing the Boundaries of Nonoperative Management -- 2.3.5 Quality of Life Implications -- 2.4 Conclusion -- References -- 3 Quality of Life and Survivorship in Extended Pelvic Resection for Advanced and Recurrent Malignancy -- 3.1 Introduction -- 3.2 Quality of Life Outcomes -- 3.2.1 Physical Function -- 3.2.2 Psychological Function -- 3.2.3 Role Function -- 3.2.4 Sexual Function -- 3.2.5 Body Image -- 3.2.6 Occupational and Financial Impact -- 3.2.7 Global QoL and General Health -- 3.2.8 QoL Assessment -- 3.3 Cancer Survivorship.3.4 After-Care Models -- 3.5 Symptom Management -- 3.6 Pain -- 3.7 Stoma Care -- 3.8 Empty Pelvis Syndrome -- 3.9 Fatigue -- 3.10 Mobility -- 3.11 Conclusion -- References -- 4 Lynch Syndrome -- 4.1 Introduction -- 4.2 History and Epidemiology -- 4.2.1 History of Lynch Syndrome -- 4.2.2 Epidemiology -- 4.2.3 Gene-Specific Cancer Risk -- 4.3 Diagnosis of Lynch Syndrome: MMR Testing -- 4.4 Biology of Lynch Syndrome -- Molecular Pathways -- 4.5 Pathways to Carcinogenesis -- Adenomatous and Non-adenomatous -- 4.5.1 Cancer from pMMR Adenoma -- 4.5.2 Cancer from dMMR Precursor, Adenoma -- 4.5.3 Cancer from dMMR Precursor, 'Non-Polypous' Route -- 4.6 Role of Surveillance Colonoscopy -- 4.6.1 Quality Factors in Colonoscopy -- 4.6.2 Advanced Imaging Techniques -- 4.6.3 Variables in Sidedness Affecting Risk Reduction -- 4.6.4 Frequency of Colonoscopy -- 4.6.5 Barriers to Colonoscopy Adherence -- 4.7 Colorectal Surgical Management of Lynch Syndrome -- 4.7.1 Extensive or Segmental Resection? -- 4.8 Prophylactic Surgery and Screening in Gynaecological Cancer -- 4.8.1 Gene-Specific Risk and Risk Reduction Surgery -- 4.8.2 Considerations Post-surgery -- 4.8.3 Pathological Features of Gynaecologic Cancers in Lynch Syndrome -- 4.8.4 Gynaecological Surveillance -- 4.9 Role of Screening in Other Cancers -- 4.9.1 Upper Gastrointestinal (GI) Cancer Screening -- 4.9.2 Urological Cancer Screening -- Urothelial and Prostate -- 4.9.3 Pancreatic Screening -- 4.9.4 Diagnostic Testing Strategies Pan-Cancer Approach -- 4.10 Lifestyle and Chemoprevention -- 4.10.1 Environmental/Lifestyle Modifiers in Lynch Syndrome -- 4.10.2 Pharmacologic Agents -- 4.10.3 Endometrial Risk Reducing Agents -- 4.11 Oncological Management: Radical and Advanced -- 4.11.1 CRC -- 4.11.2 Immunotherapy -- the Basics -- 4.11.3 Clinical Trial Data for Use of Immunotherapy in CRC: Sporadic and Germline.4.11.4 Targeted Treatments in LS Associated Gynaecological Cancers -- 4.11.5 Toxicities Related to Immune Checkpoint Blockade -- 4.11.6 Vaccine Based Therapies -- 4.12 Future Directions -- 4.13 Conclusion -- References -- 5 Neoadjuvant Therapy in Colon Cancer -- 5.1 Introduction -- 5.2 Rationale for Neoadjuvant Chemotherapy -- 5.3 Evidence on Neoadjuvant Chemotherapy -- 5.4 Current Status and Remaining Questions on Neoadjuvant Chemotherapy -- 5.5 Circulating Tumour DNA and Adjuvant Therapy -- 5.6 Immunotherapy-Immune Checkpoint Inhibition (ICI) -- 5.6.1 Deficient Mismatch Repair (dMMR) and Microsatellite Instability (MSI) -- 5.6.2 Neoadjuvant Immunotherapy in Colorectal Cancer -- 5.7 Conclusions -- References -- 6 Appendix Neoplasms -- 6.1 The Normal Appendix -- 6.1.1 Histopathology -- 6.1.2 Function -- 6.1.3 Appearances on Imaging -- 6.2 Pathology of Appendix Tumours -- 6.2.1 Neuroendocrine Neoplasms -- 6.2.2 Appendiceal Mucinous Neoplasms -- 6.2.3 Appendix Adenocarcinoma -- 6.2.4 Goblet Cell Adenocarcinoma -- 6.3 Appendiceal Neuroendocrine Tumours -- 6.3.1 Clinical Presentation -- 6.3.2 Investigations -- 6.3.3 Management -- 6.3.4 Surveillance and Outcomes -- 6.4 Appendiceal Mucinous Neoplasms -- 6.4.1 Clinical Presentation -- 6.4.2 Pseudomyxoma Peritonei -- 6.4.3 Investigations -- 6.4.4 Surgical Management -- 6.4.5 Multi-visceral Transplantation -- 6.4.6 Systemic Anti-cancer Therapy (SACT) -- 6.4.7 Surveillance and Outcomes -- 6.5 Appendix Adenocarcinoma -- 6.5.1 Clinical Presentation -- 6.5.2 Investigations -- 6.5.3 Surgical Management -- 6.5.4 Systemic Anti-cancer Therapy -- 6.5.5 Surveillance and Outcomes -- 6.6 Goblet Cell Adenocarcinoma -- 6.6.1 Clinical Presentation -- 6.6.2 Investigations -- 6.6.3 Surgical Management -- 6.6.4 Systemic Anti-Cancer Therapy (SACT) -- 6.6.5 Surveillance and Outcomes -- 6.7 Referring to Specialist Services.6.8 Current Research and Future Directions -- 6.9 Conclusion -- References -- 7 Patient Optimisation for Colorectal Surgery -- 7.1 Introduction -- 7.2 Definition of Patient Optimisation: Preassessment and Prehabilitation -- 7.2.1 Pre-assessment -- 7.2.2 Prehabilitation -- 7.3 The Evidence for the Effectiveness of Prehabilitation -- 7.3.1 Patient Safety and Feasibility -- 7.3.2 Assessment of Prehabilitation -- 7.3.3 Trials, Systematic Reviews and Meta-Analyses -- 7.3.4 The Future of Prehabilitation -- 7.4 Conclusion -- References -- 8 Empty Pelvis Syndrome Complication Management Following Pelvic Exenteration -- 8.1 Introduction -- 8.2 Empty Pelvis Syndrome -- 8.3 Prevention Strategies -- 8.3.1 Negative Pressure -- 8.3.2 Myocutaneous Flap Reconstruction -- 8.3.3 Mesh -- 8.3.4 Spacers -- 8.4 Summary -- 8.5 Complications and Management of Empty Pelvis Syndrome -- 8.5.1 Pelvic Collection -- 8.5.2 Haemorrhagic Complications -- 8.5.3 Wound Complications -- 8.5.4 Enteroperineal Fistula -- 8.5.5 Perineal Hernia -- 8.5.6 Conclusion -- References -- 9 Contemporary Management of the Open Abdomen -- 9.1 Introduction -- 9.2 Indications for an Open Abdomen -- 9.2.1 Trauma and the Damage Control Laparotomy -- 9.2.2 Intra-Abdominal Hypertension and Abdominal Compartment Syndrome -- 9.2.3 Peritonitis and Intra-Abdominal Sepsis -- 9.2.4 Acute Mesenteric Ischaemia, Pancreatitis, and Burns Without Abdominal Trauma -- 9.3 Management of the Open Abdomen -- 9.3.1 Temporary Abdominal Closure Dressings -- 9.3.2 Static Temporary Abdominal Closure -- 9.3.3 Dynamic Temporary Abdominal Closure -- 9.3.4 Mixed Techniques -- 9.3.5 Vacuum-Assisted Wound Closure Using Mesh-Mediated Fascial Traction -- 9.3.6 Immediate Management of an Enteroatmospheric Fistula -- 9.4 Conclusion -- References -- 10 Anastomotic Techniques for Crohn's Surgery.10.1 Surgical Principles in Crohn's Disease -- 10.2 Restorative Surgery Techniques After Bowel Resection -- 10.3 Anastomotic Techniques After Ileocaecal Resection -- 10.3.1 Side-to-Side Ileocolonic Anastomosis -- 10.3.2 End-to-End Handsewn Ileocolonic Anastomosis -- 10.3.3 End-to-Side and Side-to-End Ileocolonic Anastomosis -- 10.3.4 Antimesenteric Hand-Sewn Functional End-to-End Anastomosis: Kono-S Anastomosis -- 10.3.5 Additional Anastomotic Techniques -- 10.4 Extracorporeal and Intracorporeal Anastomoses -- 10.5 Restorative Techniques After Colectomy, Proctocolectomy and Upper Gastrointestinal Surgery -- 10.5.1 Ileo-Rectal Anastomosis -- 10.5.2 Ileal Pouch-Anal Anastomosis and Coloanal Anastomosis -- 10.5.3 Surgical Management of the Upper Gastrointestinal Crohn's Disease Manifestations -- 10.6 Bowel-Sparing Surgery: Stricturoplasties -- 10.6.1 Heinecke-Mikulicz-Like Stricturoplasties -- 10.6.2 Intermediate Stricturoplasty Procedures -- 10.6.3 Enteroenterostomies -- 10.7 Complications in Crohn's Disease Surgery -- 10.8 Considerations on Disease Recurrence -- 10.9 Conclusions and Future Perspectives -- References -- 11 The Modern Management of Haemorrhoids -- 11.1 Introduction -- 11.2 Pathogenesis and Classification -- 11.3 Conservative Management -- 11.3.1 Drug Therapy -- 11.3.2 Outpatient Treatment -- 11.3.3 'Walk in Walk Out' Therapy -- 11.4 Surgical Therapy -- 11.4.1 Haemorrhoidectomy -- 11.4.2 Procedure for Prolapsed Haemorrhoids -- 11.4.3 Doppler Guided Haemorrhoidal Artery Ligation -- 11.4.4 Laser -- 11.5 Special Situations -- 11.5.1 Thrombosed External Haemorrhoids -- 11.5.2 Perianal Haematoma -- 11.5.3 Haemorrhoids in Pregnancy -- 11.5.4 Anticoagulants -- 11.5.5 Immunocompromised -- 11.5.6 Haemorrhoids in Inflammatory Bowel Disease -- 11.6 Conclusion and an Evidence-Based Algorithm of Care -- References.12 Microbiome Manipulation in Coloproctology.Evans Martyn1743052Davies Mark431869Harries Rhiannon1743053Beynon John528249MiAaPQMiAaPQMiAaPQ9910865234503321Coloproctology4169770UNINA